FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ghulam Mufti

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Athar Aziz; E Joanna Baxter; Philip A Beer; Anthony J Bench; Peter J Campbell; Clara Yujing Cheong; Keefe Chng; Carol Edwards; Anne C Ferguson-Smith; Dionne Gray; Eva Hellstrom-Lindberg; Mitsuteru Ito; Rebecca Kelley; Jean-Jacques Kiladjian; Kirsten McEwen; Mary Frances McMullin; Ghulam J Mufti; Jyoti Nangalia; Marilyn B Renfree; Yvonne Silber; Anthony R Green
Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions.
Pramila Krishnamurthy; Austin G Kulasekararaj; Zi Yi Lim; Judith C W Marsh; Linda D Barber; Hugues de Lavallade; Stephen Devereux; Robin M Ireland; Michelle Kenyon; Antonio Pagliuca; Rachel M Pearce; Victoria T Potter; Ghulam J Mufti
Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes.
Austin G Kulasekararaj; Nicholas C Lea; Judith C Marsh; Syed A Mian; Azim Mohamedali; Barbara Czepulkowski; Joop Gäken; Robin Ireland; Pramila Krishnamurthy; Coralie Pennaneach; Sabine Pomplun; Alexander E Smith; Ghulam J Mufti
TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ghulam Mufti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Athar Aziz; E Joanna Baxter; Philip A Beer; Anthony J Bench; Peter J Campbell; Clara Yujing Cheong; Keefe Chng; Carol Edwards; Anne C Ferguson-Smith; Dionne Gray; Eva Hellstrom-Lindberg; Mitsuteru Ito; Rebecca Kelley; Jean-Jacques Kiladjian; Kirsten McEwen; Mary Frances McMullin; Ghulam J Mufti; Jyoti Nangalia; Marilyn B Renfree; Yvonne Silber; Anthony R Green
Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions.
The Journal of clinical investigation 2013;123(5):2169-82.
2013: Pramila Krishnamurthy; Austin G Kulasekararaj; Zi Yi Lim; Judith C W Marsh; Linda D Barber; Hugues de Lavallade; Stephen Devereux; Robin M Ireland; Michelle Kenyon; Antonio Pagliuca; Rachel M Pearce; Victoria T Potter; Ghulam J Mufti
Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(4):562-8.
2013: Austin G Kulasekararaj; Nicholas C Lea; Judith C Marsh; Syed A Mian; Azim Mohamedali; Barbara Czepulkowski; Joop Gäken; Robin Ireland; Pramila Krishnamurthy; Coralie Pennaneach; Sabine Pomplun; Alexander E Smith; Ghulam J Mufti
TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.
British journal of haematology 2013;160(5):660-72.
2012: Bernd B Zeisig; Austin G Kulasekararaj; Ghulam J Mufti; Chi Wai So
SnapShot: Acute myeloid leukemia.
Cancer cell 2012;22(5):698-698.e1.
2012: Austin G Kulasekararaj; Ghulam J Mufti
The non-transplant treatment of myelodysplastic syndromes-what's on the horizon?
Seminars in hematology 2012;49(4):350-60.
2012: Arnon Nagler; Dietger Niederwieser; Eefke Petersen; Vanderson Rocha; Avichai Shimoni; Gerard J Socié; Lars Vindelov; Renate Arnold; Andrea Bacigalupo; Didier Blaise; Paul Brown; Jan J Cornelissen; Hakan Goker; John Gribben; Jeroen J W M Janssen; Myriam Labopin; Claes Malm; Noel Milpied; Mohamad Mohty; Ghulam J Mufti
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT.
European journal of haematology 2012;89(3):206-13.
2012: Arnon Nagler; Dietger Niederwieser; Vanderson Rocha; Nigel H Russell; Avichai Shimoni; Axel R Zander; Ghulam J Mufti; Renate Arnold; Donald W Bunjes; Jan J Cornelissen; Charles Craddock; Arnold Ganser; Hildegard Greinix; Graham H Jackson; Slawomira Kyrcz-Krzemien; Myriam Labopin; Mohamad Mohty
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1422-9.
2012: Rachel H Westbrook; Nigel D Heaton; Michael A Heneghan; Nicholas C Lea; Azim Mohamedali; John G O'Grady; David W Orr; Lara N Roberts; Alexander E Smith; Julia Wendon; Ghulam J Mufti
Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012;18(7):819-27.
2012: M Mansour Ceesay; Stephen Devereux; Paul Fields; Aloysius Ho; Estella Matutes; Ghulam J Mufti; Sylwia Simpson; Graham P Taylor; Jamie Cavenagh; ANTONIO PAGLIUCA
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
Leukemia research 2012;36(7):857-61.
2012: Andres Jerez; Seiji Kojima; Austin G Kulasekararaj; Alan List; Jacqueline Boultwood; Anna Jankowska; Hideki Makishima; A MICHAEL MCDEVITT; Kathy McGraw; Azim Mohamedali; Alison R Moliterno; Ghulam J Mufti; Hideki Muramatsu; Christine L O'Keefe; Andrea Pellagatti; Bartlomiej Przychodzen; Mikkael A Sekeres; Yuka Sugimoto; Ramon Tiu; Amit Verma; Valeria Visconte; Jaroslaw P Maciejewski
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
Blood 2012;119(25):6109-17.
2012: Judith C Marsh; Ghulam J Mufti; Rosi Oneto; Jakob R Passweg; Antonio M Risitano; Alexander Roth; Philip Schafhausen; Hubert Schrezenmeier; Philip Sedgwick; Gerard Socie; Andre Tichelli; Alan J Warren; Mahmoud Aljurf; H A Al-Zahrani; Andrea Bacigalupo; Alain Barrois; Tim H Brummendorf; Carlo Dufour; Modupe Elebute; Theodora Foukaneli; Anke Franzke; Sally B Killick; Shahram Kordasti
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
Blood 2012;119(23):5391-6.
2012: Karthik Ramasamy; Stephen A Schey; Justin Sturge; Mathew P Caley; Hazera Khatun; Lee Macpherson; Ghulam J Mufti; Yolanda Calle
Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells.
British journal of haematology 2012;157(5):564-79.
2012: Joop Gäken; Jie Jiang; Austin G Kulasekararaj; Farooq Malik; Azim Mohamedali; Alexander E Smith; Doris Stangl; Mahvash Tavassoli; N Shaun B Thomas; Constantinos Chronis; Farzin Farzaneh; Ghulam J Mufti
A functional assay for microRNA target identification and validation.
Nucleic acids research 2012;40(10):e75.
2012: Andres Jerez; Denise A S Batista; Lukasz Gondek; Anna Jankowska; Hideki Makishima; A MICHAEL MCDEVITT; Azim Mohamedali; Ghulam J Mufti; Christine L O'Keefe; Bartlomiej Przychodzen; Mikkael A Sekeres; Ramon Tiu; Jaroslaw P Maciejewski
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(12):1343-9.
2012: Shahram Kordasti; Austin G Kulasekararaj; Judith Marsh; Syed A Mian; Azim Mohamedali; Pilar Perez Abellan; Sufyan Al-Khan; Nana Benson-Quarm; Benedetta Costantini; Farzin Farzaneh; Jie Jiang; Thomas Seidl; Alexander Smith; Caroline Veen; Ghulam J Mufti
Functional characterization of CD4+ T cells in aplastic anemia.
Blood 2012;119(9):2033-43.
2012: Uwe Platzbecker; Valeria Santini; Francesc Solé; Arjan A van de Loosdrecht; Claudia Haferlach; Jaroslaw P Maciejewski; Ghulam J Mufti; Sophie Park; Detlef Haase
Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop.
Leukemia research 2012;36(3):264-70.
2012: Ghulam J Mufti; Victoria Potter
Myelodysplastic syndromes: who and when in the course of disease to transplant.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2012;2012():49-55.
2012: Stephen J Orr; Thivyan Thayaparan; Rong Wang; Eric Blanc; Daniel R Boutz; Constantinos Chronis; Emma Hamilton; Nicholas C Lea; Edward M Marcotte; Hanna Milewicz; Ghulam J Mufti; N Shaun B Thomas
Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entry.
Molecular systems biology 2012;8():573.
2011: Emma Craythorne; Anthony du Viver; Ghulam J Mufti; Saman Warnakulasuriya
Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2011;40(8):616-20.
2011: Judith C Marsh; Ghulam J Mufti; Victoria Potter; Nigel Russell; Vikas Gupta; Janet Hayden; Aloysius Y Ho; Robin M Ireland; M Serajul Islam; Mickey B Koh; Ziyi Lim; David I Marks; Antonio Pagliuca
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.
Blood 2011;118(8):2351-7.
2011: W Nagi; V Potter; L Reiff-Zall; V Tindell; A Abdullah; Aloysius Y Ho; Michelle Kenyon; P Krishnamurthy; N Lea; Ziyi Lim; J Marsh; Ghulam J Mufti; ANTONIO PAGLIUCA
Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis.
Leukemia research 2011;35(8):998-1000.
2011: Lewis R Silverman; Pierre Fenaux; Norbert Gattermann; Steven D Gore; Eva Hellström-Lindberg; Alan F List; Ghulam J Mufti; Valeria Santini; Guillermo Sanz; John F Seymour
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes.
Cancer 2011;117(12):2697-702.
2011: Martin Jädersten; Leonie Saft; Alexander Smith; Austin Kulasekararaj; Sabine Pomplun; Gudrun Göhring; Anette Hedlund; Robert Hast; Brigitte Schlegelberger; Anna Porwit; Eva Hellström-Lindberg; Ghulam J Mufti
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):1971-9.
2011: Robert P E Sarkany; Sally H Ibbotson; Sharon D Whatley; Clifford M Lawrence; Pamela Gover; Ghulam J Mufti; Gillian M Murphy; Gillian S Masters; Michael N Badminton; George H Elder
Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria.
The Journal of investigative dermatology 2011;131(5):1172-5.
2011: Ramon Tiu; Lukasz Gondek; Christine L O'Keefe; Paul Elson; Jungwon Huh; Azim Mohamedali; Austin Kulasekararaj; Anjali Advani; Ronald Paquette; Alan F List; Mikkael A Sekeres; A MICHAEL MCDEVITT; Ghulam J Mufti; Jaroslaw P Maciejewski
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Blood 2011;117(17):4552-60.
2011: Karthik Ramasamy; Shameem Mahmood; Ziyi Lim; Sophie Corderoy; Stephen Devereux; Ghulam J Mufti; Antonio Pagliuca; Stephen Schey
Alemtuzumab-based reduced-intensity conditioning allogeneic transplantation for myeloma and plasma cell leukemia - a single-institution experience.
Clinical lymphoma, myeloma & leukemia 2011;11(2):242-5.
2011: John M Bennett; Terry J Hamblin; Ghulam J Mufti
The Myelodysplastic Syndromes (MDS) Foundation: a retrospective analysis of a nonprofit foundation.
Leukemia research 2011;35(3):283-5.
2011: Sydney Shall; Nicola Curtin; Farzin Farzaneh; Terry Gaymes; Ghulam J Mufti
The use of PARP inhibitors in cancer therapy: use as adjuvant with chemotherapy or radiotherapy; use as a single agent in susceptible patients; techniques used to identify susceptible patients.
Methods in molecular biology (Clifton, N.J.) 2011;780():239-66.
2010: John F Seymour; Pierre Fenaux; Lewis R Silverman; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Alan F List; Steven D Gore; Jay Backstrom; David McKenzie; C L Beach
Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes.
Critical reviews in oncology/hematology 2010;76(3):218-27.
2010: Alexander E Smith; Azim Mohamedali; Austin Kulasekararaj; Ziyi Lim; Joop Gäken; Nicholas C Lea; Bartlomiej Przychodzen; Syed A Mian; Erick E Nasser; Claire Shooter; Nigel B Westwood; Corinna Strupp; Norbert Gattermann; Jaroslaw P Maciejewski; Ulrich Germing; Ghulam J Mufti
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.
Blood 2010;116(19):3923-32.
2010: Andrea G S Buggins; Chris Pepper; Piers E M Patten; Saman Hewamana; Satyen Gohil; Jane Moorhead; Najeem'deen Folarin; Deborah Yallop; N Shaun B Thomas; Ghulam J Mufti; Christopher Fegan; Stephen Devereux
Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
Cancer research 2010;70(19):7523-33.
2010: P Krishnamurthy; Ziyi Lim; W Nagi; Michelle Kenyon; A Mijovic; R Ireland; J Marsh; Aloysius Y Ho; Ghulam J Mufti; ANTONIO PAGLIUCA
Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.
Bone marrow transplantation 2010;45(10):1502-7.
2010: Valeria Santini; Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Lewis R Silverman; Alan List; Steven D Gore; John F Seymour; Jay Backstrom; Charles L Beach
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*.
European journal of haematology 2010;85(2):130-8.
2010: S J Orr; T Gaymes; D Ladon; C Chronis; Barbara Czepulkowski; R Wang; Ghulam J Mufti; E M Marcotte; N S B Thomas
Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycle.
Oncogene 2010;29(26):3803-14.
2010: Katie Matthews; ZiYi Lim; Laurence Pearce; ANTONIO PAGLIUCA; J Alejandro Madrigal; Ghulam J Mufti; Linda D Barber
Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.
British journal of haematology 2010;149(6):879-89.
2010: D W Orr; Raj K Patel; Nicholas C Lea; R H Westbrook; John G O'Grady; N D Heaton; ANTONIO PAGLIUCA; Ghulam J Mufti; Michael A Heneghan
The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis.
Alimentary pharmacology & therapeutics 2010;31(12):1330-6.
2010: Pierre Fenaux; Norbert Gattermann; John F Seymour; Eva Hellström-Lindberg; Ghulam J Mufti; Ulrich Duehrsen; Steven D Gore; Fernando Ramos; Odile Beyne-Rauzy; Alan List; David McKenzie; Jay Backstrom; Charles L Beach
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.
British journal of haematology 2010;149(2):244-9.
2010: Ziyi Lim; Wendy Ingram; Ronald Brand; A Ho; Michelle Kenyon; Stephen Devereux; J Marsh; Ghulam J Mufti; ANTONIO PAGLIUCA
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML.
Bone marrow transplantation 2010;45(4):633-9.
2010: Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Norbert Gattermann; Ulrich Germing; Guillermo Sanz; Alan F List; Steven D Gore; John F Seymour; Hervé Dombret; Jay Backstrom; Linda Zimmerman; David McKenzie; C L Beach; Lewis R Silverman
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):562-9.
2010: Ziyi Lim; Ronald Brand; Rodrigo Martino; Anja van Biezen; Jürgen Finke; Andrea Bacigalupo; Dietrich Beelen; Agnes Devergie; Emilie Alessandrino; Roel Willemze; Tapani Ruutu; Marc Boogaerts; Michele Falda; Jean-Pierre Jouet; Dietger Niederwieser; Nicolaus Kroger; Ghulam J Mufti; Theo M De Witte
Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(3):405-11.
2009: Irit Avivi; Silvia Montoto; Carme Canals; John Maertens; Haifa Al-Ali; Ghulam J Mufti; Jürgen Finke; Anton Schattenberg; Renato Fanin; Jan J Cornelissen; Jean-Paul Vernant; Nigell Russell; Yves Beguin; Kirsty Thomson; Leo F Verdonck; Guido Kobbe; Herve Tilly; Gerard Socié; Anna Sureda
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
British journal of haematology 2009;147(5):719-28.
2009: David J Kuter; Ghulam J Mufti; Barbara J Bain; Robert P Hasserjian; Wende Davis; Mark Rutstein
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.
Blood 2009;114(18):3748-56.
2009: Wendy Ingram; Shahram Kordasti; Lucas Chan; Linda D Barber; Gee J Tye; Nicola R Hardwick; Ghulam J Mufti; Farzin Farzaneh
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of cultures.
Cancer immunology, immunotherapy : CII 2009;58(10):1679-90.
2009: Azim Mohamedali; Alexander E Smith; Joop Gaken; Nicholas C Lea; Syed A Mian; Nigel B Westwood; Corinna Strupp; Norbert Gattermann; Ulrich Germing; Ghulam J Mufti
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):4002-6.
2009: Alexander E Smith; Constantinos Chronis; Manolis Christodoulakis; Stephen J Orr; Nicholas C Lea; Natalie A Twine; Akshay Bhinge; Ghulam J Mufti; N Shaun B Thomas
Epigenetics of human T cells during the G0-->G1 transition.
Genome research 2009;19(8):1325-37.
2009: Jean E Goasguen; John M Bennett; Barbara J Bain; Teresa Vallespi; Richard Brunning; Ghulam J Mufti
Morphological evaluation of monocytes and their precursors.
Haematologica 2009;94(7):994-7.
2009: Katie Matthews; ZiYi Lim; Behdad Afzali; Laurence Pearce; Atiyeh Abdallah; Shahram Kordasti; ANTONIO PAGLIUCA; Giovanna Lombardi; J Alejandro Madrigal; Ghulam J Mufti; Linda D Barber
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.
Haematologica 2009;94(7):956-66.
2009: Wendy Ingram; Lucas Chan; Hayrettin Guven; David Darling; Shahram Kordasti; Nicola R Hardwick; Linda Barber; Ghulam J Mufti; Farzin Farzaneh
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study.
British journal of haematology 2009;145(6):749-60.
2009: Terry J Gaymes; Sydney Shall; Lee J MacPherson; Natalie A Twine; Nicholas C Lea; Farzin Farzaneh; Ghulam J Mufti
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.
Haematologica 2009;94(5):638-46.
2009: Sergio Querol; Ghulam J Mufti; Steven G E Marsh; ANTONIO PAGLIUCA; Ann-Margaret Little; Bronwen E Shaw; Robert Jeffery; Joan Garcia; John M Goldman; J Alejandro Madrigal
Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?
Haematologica 2009;94(4):536-41.
2009: Shahram Kordasti; Behdad Afzali; Ziyi Lim; Wendy Ingram; Janet Hayden; Linda Barber; Katie Matthews; Rajani Chelliah; Barbara Guinn; Giovanna Lombardi; Farzin Farzaneh; Ghulam J Mufti
IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome.
British journal of haematology 2009;145(1):64-72.
2009: Pierre Fenaux; Ghulam J Mufti; Eva Hellstrom-Lindberg; Valeria Santini; Carlo Finelli; Aristoteles Giagounidis; Robert Schoch; Norbert Gattermann; Guillermo Sanz; Alan List; Steven D Gore; John F Seymour; john bennett; John Byrd; Jay Backstrom; Linda Zimmerman; David McKenzie; Cl Beach; Lewis R Silverman
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
The lancet oncology 2009;10(3):223-32.
2009: Adam T C Cheuk; James W Wells; Lucas Chan; Nigel B Westwood; Stuart A Berger; Hideo Yagita; Ko Okumura; Farzin Farzaneh; Ghulam J Mufti; Barbara-Ann Guinn
Anti-tumor immunity in a model of acute myeloid leukemia.
Leukemia & lymphoma 2009;50(3):447-54.
2009: Ziyi Lim; G Cook; P R Johnson; Anne Parker; M Zuckerman; D Marks; H Wiltshire; Ghulam J Mufti; ANTONIO PAGLIUCA
Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation.
Leukemia research 2009;33(2):244-9.
2009: Agota Szende; Caroline Schaefer; Thomas F Goss; Kathy Heptinstall; Robert Knight; Michael Lübbert; Barbara Deschler; Pierre Fenaux; Ghulam J Mufti; Sally Killick; Alan F List
Valuation of transfusion-free living in MDS: results of health utility interviews with patients.
Health and quality of life outcomes 2009;7():81.
2009: Azim Mohamedali; Barbara-ann Guinn; Satyajit Sahu; N Shaun B Thomas; Ghulam J Mufti
Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients.
British journal of haematology 2009;144(2):263-5.
2009: Azim Mohamedali; Ghulam J Mufti
Van-den Berghe's 5q- syndrome in 2008.
British journal of haematology 2009;144(2):157-68.
2009: David B Savage; Robert K Semple; Menna R Clatworthy; Paul A Lyons; B Paul Morgan; Elaine Cochran; Phillip Gorden; Philippa Raymond-Barker; Peter R Murgatroyd; Claire Adams; Ian Scobie; Ghulam J Mufti; Graeme J M Alexander; Sathia Thiru; Incoronata Murano; Saverio Cinti; Afzal N Chaudhry; Kenneth G C Smith; Stephen O'Rahilly
Complement abnormalities in acquired lipodystrophy revisited.
The Journal of clinical endocrinology and metabolism 2009;94(1):10-6.
2008: Terry J Gaymes; Sydney Shall; Farzin Farzaneh; Ghulam J Mufti
Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors.
Haematologica 2008;93(12):1886-9.
2008: Ghulam J Mufti; john bennett; Jean Goasguen; Barbara J Bain; Irith Baumann; Richard Brunning; Mario Cazzola; Pierre Fenaux; Ulrich Germing; Eva Hellström-Lindberg; Itsuro Jinnai; Atsushi Manabe; Akira Matsuda; Charlotte M Niemeyer; Guillermo Sanz; Masao Tomonaga; Teresa Vallespi; Ayami Yoshimi
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
Haematologica 2008;93(11):1712-7.
2008: Ghulam J Mufti; Tara L Chen
Changing the treatment paradigm in myelodysplastic syndromes.
Cancer control : journal of the Moffitt Cancer Center 2008;15 Suppl():14-28.
2008: Jaroslaw P Maciejewski; Ghulam J Mufti
Whole genome scanning as a cytogenetic tool in hematologic malignancies.
Blood 2008;112(4):965-74.
2008: Aleksandar Mijovic; Atiyeh Abdallah; Laurence Pearce; Khalid Tobal; Ghulam J Mufti
Effects on erythropoiesis of alemtuzumab-containing reduced intensity and standard conditioning regimens.
British journal of haematology 2008;142(3):444-52.
2008: Piers E M Patten; Andrea G S Buggins; Julie Richards; Andrew Wotherspoon; Jon Salisbury; Ghulam J Mufti; Terry J Hamblin; Stephen Devereux
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment.
Blood 2008;111(10):5173-81.
2008: Aristoteles Giagounidis; Pierre Fenaux; Ghulam J Mufti; Petra Muus; Uwe Platzbecker; Guillermo Sanz; Larry Cripe; Marie von Lilienfeld-Toal; Richard A Wells
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes.
Annals of hematology 2008;87(5):345-52.
2008: Ziyi Lim; Aloysius Y Ho; S Abrahams; A Fensom; M Aldouri; ANTONIO PAGLIUCA; C Shaw; Ghulam J Mufti
Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease.
Bone marrow transplantation 2008;41(9):831-2.
2008: Wendy Ingram; Stephen Devereux; Emma P Das-Gupta; Nigel H Russell; Andrew P Haynes; Jennifer L Byrne; Bronwen E Shaw; Andrew McMillan; Juan Gonzalez; Aloysius Ho; Ghulam J Mufti; ANTONIO PAGLIUCA
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
British journal of haematology 2008;141(2):235-43.
2008: Lallindra Gooneratne; Waseem Nagi; Ziyi Lim; Aloysius Y Ho; Stephen Devereux; Antonio Pagliuca; Ghulam J Mufti
Sarcoidosis and haematological malignancies: is there an association?
British journal of haematology 2008;141(2):260-2.
2008: J S Williams; Ghulam J Mufti; A W P Du Vivier; Jonathan R Salisbury; Daniel Creamer
Leucoderma and leucotrichia in association with chronic cutaneous graft-versus-host disease.
The British journal of dermatology 2008;158(1):172-4.
2007: Nader Omidvar; Scott C Kogan; Stephanie Beurlet; Carole le Pogam; Anne Janin; Robert R West; Maria-Elena Noguera; Murielle Reboul; Annie Soulie; Christophe Leboeuf; Niclas Setterblad; Dean W Felsher; Eric Lagasse; Azim Mohamedali; N Shaun B Thomas; Pierre Fenaux; Michaela Fontenay; Marika Pla; Ghulam J Mufti; Irving Weissman; Christine Chomienne; Rose Ann Padua
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.
Cancer research 2007;67(24):11657-67.
2007: Azim Mohamedali; Joop Gäken; Natalie A Twine; Wendy Ingram; Nigel B Westwood; Nicholas C Lea; Janet Hayden; Nora Donaldson; Carlo Aul; Norbert Gattermann; Aristotle Giagounidis; Ulrich Germing; Alan F List; Ghulam J Mufti
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.
Blood 2007;110(9):3365-73.
2007: Ziyi Lim; Wendy Ingram; R Brand; M Akthari; Dragana Milojkovic; Aloysius Y Ho; Stephen Devereux; ANTONIO PAGLIUCA; R F Duarte; Ghulam J Mufti
Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival.
Bone marrow transplantation 2007;40(8):747-52.
2007: Feyruz V Rassool; Terry J Gaymes; Nader Omidvar; Nicola Brady; Stephanie Beurlet; Marika Pla; Murielle Reboul; Nicholas Lea; Christine Chomienne; Nicholas S B Thomas; Ghulam J Mufti; Rose Ann Padua
Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?
Cancer research 2007;67(18):8762-71.
2007: Daniel Creamer; Claire L Martyn-Simmons; G E N Osborne; Michelle Kenyon; Jonathan R Salisbury; Stephen Devereux; ANTONIO PAGLIUCA; Aloysius Y Ho; Ghulam J Mufti; A W P Du Vivier
Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Archives of dermatology 2007;143(9):1157-62.
2007: Frances A K Denniss; Angela Breslin; Wendy Ingram; Nicola R Hardwick; Ghulam J Mufti; Barbara Guinn
The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells.
British journal of haematology 2007;138(5):668-9.
2007: K Raj; A John; A Ho; C Chronis; S Khan; J Samuel; S Pomplun; N Shaun B Thomas; Ghulam J Mufti
CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine.
Leukemia 2007;21(9):1937-44.
2007: Ziyi Lim; Laurence Pearce; Aloysius Y Ho; Linda Barber; Wendy Ingram; Monica Usai; Khalid Tobal; Stephen Devereux; ANTONIO PAGLIUCA; Ghulam J Mufti
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
British journal of haematology 2007;138(4):517-26.
2007: Shahram Kordasti; Wendy Ingram; Janet Hayden; David Darling; Linda Barber; Behdad Afzali; Giovanna Lombardi; Marcin W Wlodarski; Jaroslaw P Maciejewski; Farzin Farzaneh; Ghulam J Mufti
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).
Blood 2007;110(3):847-50.
2007: Ziyi Lim; Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti; ANTONIO PAGLIUCA; J Wade; M Smith
False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experience.
The Journal of infection 2007;55(2):201-2.
2007: J S Williams; Ghulam J Mufti; S Powell; Jonathan R Salisbury; Elisabeth M Higgins
Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed acute myeloid leukaemia.
Clinical and experimental dermatology 2007;32(4):395-7.
2007: Pierre Fenaux; Azra Raza; Ghulam J Mufti; Carlo Aul; Ulrich Germing; Andrew Lamb; Larry D Cripe; René Kerstens; Peter De Porre; Razelle Kurzrock
A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome.
Blood 2007;109(10):4158-63.
2007: J M L White; Daniel Creamer; A W P Du Vivier; ANTONIO PAGLIUCA; Aloysius Y Ho; Stephen Devereux; Jonathan R Salisbury; Ghulam J Mufti
Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges.
The British journal of dermatology 2007;156(5):1032-8.
2007: Karthik Ramasamy; Janet Hayden; Ziyi Lim; Ghulam J Mufti; Aloysius Y Ho
Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy.
British journal of haematology 2007;137(4):374-5.
2007: K Raj; A Ho; J D Creamer; A W P Du Vivier; Jonathan R Salisbury; Ghulam J Mufti
Complete response of deep neutrophilic dermatosis associated with myelodysplastic syndrome to 5-azacytidine.
The British journal of dermatology 2007;156(5):1039-41.
2007: L Gooneratne; Ziyi Lim; A du Vivier; Jonathan R Salisbury; A S Knisely; Aloysius Y Ho; ANTONIO PAGLIUCA; Ghulam J Mufti
Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation.
Bone marrow transplantation 2007;39(8):511-2.
2007: Wendy Ingram; Ziyi Lim; Ghulam J Mufti
Allogeneic transplantation for myelodysplastic syndrome (MDS).
Blood reviews 2007;21(2):61-71.
2007: Julie Richards; G Yvonne Morgan; Laurence Pearce; Piers E M Patten; Ghulam J Mufti; Stephen Devereux
Laser capture microscopy as a tool for the assessment of lineage-specific chimaerism from archived blood and bone marrow films.
British journal of haematology 2007;136(4):677-8.
2007: Karthik Ramasamy; Ziyi Lim; ANTONIO PAGLIUCA; Stephen Devereux; Aloysius Y Ho; Ghulam J Mufti
Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: report of three cases and review of literature.
Leukemia & lymphoma 2007;48(2):290-4.
2007: Ziyi Lim; ANTONIO PAGLIUCA; Sylwia Simpson; Simon Cottam; Max Ervine; Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti
Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data.
British journal of haematology 2007;136(3):448-50.
2007: Ziyi Lim; Bob Baker; Mark Zuckerman; Mark Zuckermann; Jim J Wade; Mansour Ceesay; Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti; ANTONIO PAGLIUCA
Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation.
The Journal of infection 2007;54(2):e83-6.
2006: Kavita Raj; Ghulam J Mufti
Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes.
Therapeutics and clinical risk management 2006;2(4):377-88.
2006: S E Moses; Ziyi Lim; M Sudhanva; Stephen Devereux; Aloysius Y Ho; ANTONIO PAGLIUCA; Mark Zuckerman; Ghulam J Mufti
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.
Journal of medical virology 2006;78(12):1560-3.
2006: K Ramasamy; Ziyi Lim; ANTONIO PAGLIUCA; R Grundy; Stephen Devereux; Aloysius Y Ho; Ghulam J Mufti
Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT).
Bone marrow transplantation 2006;38(12):823-4.
2006: M M Ceesay; Nicholas C Lea; Wendy Ingram; Nigel B Westwood; Joop Gäken; Azim Mohamedali; J Cervera; Ulrich Germing; Norbert Gattermann; Aristotle Giagounidis; Z Garcia-Casado; G Sanz; Ghulam J Mufti
The JAK2 V617F mutation is rare in RARS but common in RARS-T.
Leukemia 2006;20(11):2060-1.
2006: Rodrigo Martino; Rocio Parody; Takahiro Fukuda; Johan Maertens; Koen Theunissen; Aloysius Ho; Ghulam J Mufti; Nicolaus Kroger; Arnold R Zander; Dominik Heim; Monika Paluszewska; Dominik Selleslag; Katerina Steinerova; Per Ljungman; Simone Cesaro; Anna Nihtinen; Catherine Cordonnier; Lourdes Vazquez; Mónica López-Duarte; Javier Lopez; Rafael Cabrera; Montserrat Rovira; Stefan Neuburger; Oliver A Cornely; Ann E Hunter; Kieren Marr; Hans Jürgen Dornbusch; Hermann Einsele
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2006;108(9):2928-36.
2006: Ziyi Lim; Aloysius Y Ho; Wendy Ingram; Michelle Kenyon; Laurence Pearce; Barbara Czepulkowski; Stephen Devereux; Rafael F Duarte; ANTONIO PAGLIUCA; Ghulam J Mufti
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.
British journal of haematology 2006;135(2):201-9.
2006: D Milojković; M Aldouri; ANTONIO PAGLIUCA; Ghulam J Mufti; Stephen Devereux
Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.
Bone marrow transplantation 2006;38(6):461-2.
2006: Gabriel J Weston; Andrew J Martin; Ghulam J Mufti; Anthony J Strong; Michael J Gleeson
Hydroxyurea treatment of meningiomas: a pilot study.
Skull base : official journal of North American Skull Base Society ... [et al.] 2006;16(3):157-60.
2006: Karthik Ramasamy; Ziyi Lim; ANTONIO PAGLIUCA; Jonathan R Salisbury; Ghulam J Mufti; Stephen Devereux
Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone.
Haematologica 2006;91(8 Suppl):ECR44.
2006: Terry J Gaymes; Rose Ann Padua; Marika Pla; Stephen Orr; Nader Omidvar; Christine Chomienne; Ghulam J Mufti; Feyruz V Rassool
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?
Molecular cancer research : MCR 2006;4(8):563-73.
2006: Rodrigo Martino; Simona Iacobelli; Ronald Brand; Thekla Jansen; Anja van Biezen; Jürgen Finke; Andrea Bacigalupo; Dietrich Beelen; Josy Reiffers; Agnès Devergie; Emilie Alessandrino; Ghulam J Mufti; Renée M Y Barge; Jorge Sierra; Tapani Ruutu; Marc Boogaerts; Michele Falda; Jean-Pierre Jouet; Dietger Niederwieser; Theo de Witte
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.
Blood 2006;108(3):836-46.
2006: Lucas Chan; Nicola R Hardwick; Barbara Guinn; David Darling; Joop Gäken; Joanna Galea-Lauri; Aloysius Y Ho; Ghulam J Mufti; Farzin Farzaneh
An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Cancer immunology, immunotherapy : CII 2006;55(8):1017-24.
2006: Stella J Bowcock; Saad M B Rassam; Ziyi Lim; Susan M Ward; Madan M Ryali; Ghulam J Mufti
High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
British journal of haematology 2006;134(2):242-3.
2006: Barbara Guinn; Amanda F Gilkes; Ghulam J Mufti; Alan K Burnett; Ken Mills
The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia.
British journal of haematology 2006;134(2):238-9.
2006: Sunil Gupta; Antonio Pagliuca; Stephen Devereux; Ghulam J Mufti; Steve Schey
Life-threatening motor neurotoxicity in association with bortezomib.
Haematologica 2006;91(7):1001.
2006: Nicholas C Lea; Ziyi Lim; Nigel B Westwood; Matthew Arno; Joop Gäken; Azim Mohamedali; Ghulam J Mufti
Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia.
Leukemia 2006;20(7):1324-6.
2006: Wendy Ingram; Nicholas C Lea; J Cervera; Ulrich Germing; Pierre Fenaux; Bruno Cassinat; Jean-Jacques Kiladjian; Judit Várkonyi; P Antunovic; Nigel B Westwood; Matthew Arno; Azim Mohamedali; J Gaken; T Kontou; Barbara Czepulkowski; N A Twine; J Tamaska; J Csomer; S Benedek; Norbert Gattermann; E Zipperer; Aristotle Giagounidis; Z Garcia-Casado; G Sanz; Ghulam J Mufti
The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow.
Leukemia 2006;20(7):1319-21.
2006: Raj K Patel; Nicholas C Lea; Michael A Heneghan; Nigel B Westwood; Dragana Milojkovic; Murugaiyan Thanigaikumar; Deborah Yallop; Roopen Arya; ANTONIO PAGLIUCA; Joop Gäken; Julia Wendon; Nigel D Heaton; Ghulam J Mufti
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.
Gastroenterology 2006;130(7):2031-8.
2006: Rafael F Duarte; D Pamphilon; J Cornish; Bronwen E Shaw; D Samson; Charles Craddock; D Marks; Ghulam J Mufti; R L Powles; J F Apperley; J Alejandro Madrigal; JM Goldman
Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005.
Bone marrow transplantation 2006;37(10):901-8.
2006: Aleksandar Mijovic; Michel Delforge; Maryam Sekhavat; Barbara Czepulkowski; Ghulam J Mufti
Mobilization of hematopoietic progenitors in low-grade myelodysplastic syndromes.
Haematologica 2006;91(4):572-3.
2006: J M L White; Ghulam J Mufti; Jonathan R Salisbury; A W P Du Vivier
Cutaneous manifestations of granulocyte colony-stimulating factor.
Clinical and experimental dermatology 2006;31(2):206-7.
2006: Ziyi Lim; Sunil Gupta; Jonathan R Salisbury; David Elias; Nawaneetha K Venkatram; Ghulam J Mufti; ANTONIO PAGLIUCA
T-cell lymphoblastic lymphoma presenting as an intra-muscular mass.
British journal of haematology 2006;132(5):537.
2006: Adam T C Cheuk; Lucas Chan; Barbara Czepulkowski; Stuart A Berger; Hideo Yagita; Ko Okumura; Farzin Farzaneh; Ghulam J Mufti; Barbara Guinn
Development of a whole cell vaccine for acute myeloid leukaemia.
Cancer immunology, immunotherapy : CII 2006;55(1):68-75.
2005: Lewis R Silverman; Ghulam J Mufti
Methylation inhibitor therapy in the treatment of myelodysplastic syndrome.
Nature clinical practice. Oncology 2005;2 Suppl 1():S12-23.
2005: Stephen B Baylin; Ghulam J Mufti
Myelodysplastic syndromes (MDSs) and acute myelogenous leukemia (AML) comprise a closely linked continuum of malignant hematologic diseases. Introduction.
Nature clinical practice. Oncology 2005;2 Suppl 1():S1-3.
2005: Ziyi Lim; R Grace; Jonathan R Salisbury; Daniel Creamer; A Jayaprakasam; Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti; ANTONIO PAGLIUCA
Cardiac presentation of ALK positive anaplastic large cell lymphoma.
European journal of haematology 2005;75(6):511-4.
2005: Bronwen E Shaw; Nigel H Russell; Stephen Devereux; Emma Das-Gupta; Stephen Mackinnon; J Alejandro Madrigal; Anthony Pagliuca; Ghulam J Mufti; Jennifer L Byrne
The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.
Haematologica 2005;90(11):1562-9.
2005: Barbara Guinn; Elizabeth A Bland; Usman Lodi; Amanda P Liggins; Khalid Tobal; Sarah Petters; James W Wells; Alison H Banham; Ghulam J Mufti
Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
Biochemical and biophysical research communications 2005;335(4):1293-304.
2005: Dragana Milojkovic; Andrea G S Buggins; S Devereux; N Shaun B Thomas; Ghulam J Mufti
Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently.
Leukemia 2005;19(9):1699-702.
2005: Barbara Guinn; Amanda F Gilkes; Eleanor Woodward; Nigel B Westwood; Ghulam J Mufti; David C Linch; Alan K Burnett; Ken Mills
Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia.
Biochemical and biophysical research communications 2005;333(3):703-13.
2005: Matthew R Foxton; Lisa Knight; Alex S Knisely; Ghulam J Mufti; John O'Grady; Paolo Muiesan; Suzanne Norris
Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(7):839-42.
2005: Abdelkader Essafi; Silvia Fernández de Mattos; Yasmin A M Hassen; Inês Soeiro; Ghulam J Mufti; N Shaun B Thomas; René H Medema; Eric W-F Lam
Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells.
Oncogene 2005;24(14):2317-29.
2005: K Saunders; B Czepulkowski; R Sivalingam; J P L A Hayes; M Aldouri; M Sekhar; M Cummins; A Ho; Ghulam J Mufti
Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
Cancer genetics and cytogenetics 2005;156(2):154-7.
2004: Ghulam J Mufti
Emerging therapeutic and supportive care approaches for the myelodisplastic syndromes.
Reviews in clinical and experimental hematology 2004;8(2):E4.
2004: Dragana Milojkovic; Stephen Devereux; Nigel B Westwood; Ghulam J Mufti; N Shaun B Thomas; Andrea G S Buggins
Antiapoptotic microenvironment of acute myeloid leukemia.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(11):6745-52.
2004: Ghulam J Mufti
Pathobiology, classification, and diagnosis of myelodysplastic syndrome.
Best practice & research. Clinical haematology 2004;17(4):543-57.
2004: Aloysius Y Ho; ANTONIO PAGLIUCA; Michelle Kenyon; Jane E Parker; Aleksandar Mijovic; Stephen Devereux; Ghulam J Mufti
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning.
Blood 2004;104(6):1616-23.
2004: A Pradhan; Aleksandar Mijovic; K Mills; P Cumber; N Westwood; Ghulam J Mufti; Feyruz V Rassool
Differentially expressed genes in adult familial myelodysplastic syndromes.
Leukemia 2004;18(3):449-59.
2004: Adam T C Cheuk; Ghulam J Mufti; Barbara Guinn
Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cancer gene therapy 2004;11(3):215-26.
2004: Alison M John; N Shaun B Thomas; Ghulam J Mufti; Rose Ann Padua
Targeted therapies in myeloid leukemia.
Seminars in cancer biology 2004;14(1):41-62.
2004: Anthony P Coll; Stephen Thomas; Ghulam J Mufti
Rituximab therapy for the type B syndrome of severe insulin resistance.
The New England journal of medicine 2004;350(3):310-1.
2004: Jane E Parker; Ghulam J Mufti
The myelodysplastic syndromes: a matter of life or death.
Acta haematologica 2004;111(1-2):78-99.
2003: Azim Mohamedali; Inês Soeiro; Nicholas C Lea; Janet Glassford; Lolita Banerji; Ghulam J Mufti; Eric W-F Lam; N Shaun B Thomas
Cyclin D2 controls B cell progenitor numbers.
Journal of leukocyte biology 2003;74(6):1139-43.
2003: Feyruz V Rassool; Philip S North; Ghulam J Mufti; Ian D Hickson
Constitutive DNA damage is linked to DNA replication abnormalities in Bloom's syndrome cells.
Oncogene 2003;22(54):8749-57.
2003: D Milojkovic; K Short; Jonathan R Salisbury; Daniel Creamer; A W P Du Vivier; Ghulam J Mufti
Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia.
Leukemia 2003;17(7):1414-6.
2003: Nigel B Westwood; Ghulam J Mufti
Apoptosis in the myelodysplastic syndromes.
Current hematology reports 2003;2(3):186-92.
2003: Nicola Brady; Terry J Gaymes; Manyee Cheung; Ghulam J Mufti; Feyruz V Rassool
Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins.
Cancer research 2003;63(8):1798-805.
2003: O Fasan; C Willmott; Barbara Czepulkowski; A Baker; D Rees; J Salisbury; Ghulam J Mufti
Epstein-Barr virus-related post-transplant lymphoproliferative disorder with t(9;14)(p11-12;q32).
Cancer genetics and cytogenetics 2003;142(2):134-6.
2003: Aloysius Y Ho; Allan Deacon; G E N Osborne; Ghulam J Mufti
Precipitation of porphyria cutanea tarda by imatinib mesylate?
British journal of haematology 2003;121(2):375.
2003: Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti; ANTONIO PAGLIUCA
Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions.
Bone marrow transplantation 2003;31(7):551-7.
2003: Nicholas C Lea; Stephen J Orr; Kai Stoeber; Gareth H Williams; Eric W-F Lam; Mohammad A A Ibrahim; Ghulam J Mufti; N Shaun B Thomas
Commitment point during G0-->G1 that controls entry into the cell cycle.
Molecular and cellular biology 2003;23(7):2351-61.
2003: Nicholas C Lea; Andrea G S Buggins; Stephen J Orr; Ghulam J Mufti; N Shaun B Thomas
High efficiency protein transduction of quiescent and proliferating primary hematopoietic cells.
Journal of biochemical and biophysical methods 2003;55(3):251-8.
2003: Aloysius Y Ho; Michelle Kenyon; Ihab El-Hemaidi; Stephen Devereux; ANTONIO PAGLIUCA; Ghulam J Mufti
Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200.
Blood 2003;101(2):779-80.
2002: S P Adams; S S Sahota; Aleksandar Mijovic; Barbara Czepulkowski; Rose Ann Padua; Ghulam J Mufti; Barbara Guinn
Frequent expression of HAGE in presentation chronic myeloid leukaemias.
Leukemia 2002;16(11):2238-42.
2002: Dilek Aktas; Matthew J Arno; Feyruz V Rassool; Ghulam J Mufti
Analysis of CHK2 in patients with myelodysplastic syndromes.
Leukemia research 2002;26(11):985-7.
2002: Elizabeth Cameron; Aleksandar Mijovic; James G Herman; Stephen B Baylin; Anjala Pradhan; Ghulam J Mufti; Feyruz V Rassool
P15INK4B is not mutated in adult familial myelodysplastic syndromes.
British journal of haematology 2002;119(1):277-9.
2002: Jane E Parker; Tariq Shafi; ANTONIO PAGLIUCA; Aleksandar Mijovic; Stephen Devereux; Mike Potter; H Grant Prentice; Mamta Garg; John A Yin; Jenny Byrne; Nigel H Russell; Ghulam J Mufti
Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.
British journal of haematology 2002;119(1):144-54.
2002: Andrea G S Buggins; Ghulam J Mufti; Jonathan Salisbury; Jane Codd; Nigel B Westwood; Matthew Arno; Keith Fishlock; ANTONIO PAGLIUCA; Stephen Devereux
Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab.
Blood 2002;100(5):1715-20.
2002: Barbara Guinn; Joseph F Collin; Geng Li; Robert C Rees; Ghulam J Mufti
Optimised SEREX technique for the identification of leukaemia-associated antigens.
Journal of immunological methods 2002;264(1-2):207-14.
2002: Terry J Gaymes; Ghulam J Mufti; Feyruz V Rassool
Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer.
Cancer research 2002;62(10):2791-7.
2002: Aloysius Y Ho; S Adams; H Shaikh; ANTONIO PAGLIUCA; Stephen Devereux; Ghulam J Mufti
Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome.
Bone marrow transplantation 2002;29(10):867-9.
2002: Terry J Gaymes; Phillip S North; Nicola Brady; Ian D Hickson; Ghulam J Mufti; Feyruz V Rassool
Increased error-prone non homologous DNA end-joining--a proposed mechanism of chromosomal instability in Bloom's syndrome.
Oncogene 2002;21(16):2525-33.
2002: Barbara Czepulkowski; Anthony R Powell; ANTONIO PAGLIUCA; Ghulam J Mufti
Trisomy 10 and acute myeloid leukemia.
Cancer genetics and cytogenetics 2002;134(1):81-3.
2001: Andrea G S Buggins; Dragana Milojkovic; Matthew Arno; Nicholas C Lea; Ghulam J Mufti; N Shaun B Thomas; WJ Hirst
Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(10):6021-30.
2001: FM Keane; SE Munn; DA Buckley; D Hopster; Ghulam J Mufti; A W P Du Vivier
Neutrophilic eccrine hidradenitis in two neutropaenic patients.
Clinical and experimental dermatology 2001;26(2):162-5.
2000: Jane E Parker; Ghulam J Mufti; F Rasool; Aleksandar Mijovic; Stephen Devereux; ANTONIO PAGLIUCA
The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
Blood 2000;96(12):3932-8.
2000: T Ng; T Yeghen; ANTONIO PAGLIUCA; D S Gillett; Ghulam J Mufti
Non-caseating granulomata associated with hypocellular myelodysplastic syndrome.
Leukemia & lymphoma 2000;39(3-4):397-403.
2000: Dragana Milojkovic; Aleksandar Mijovic; C G Taylor; Ghulam J Mufti; ANTONIO PAGLIUCA
Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
British journal of haematology 2000;110(4):1013-4.
2000: T Ng; Alex Gatt; A Pagliuca; Ghulam J Mufti
Colchicine: an effective treatment for refractory malignant pericardial effusion.
Acta haematologica 2000;104(4):217-9.
1999: G Matteo Rigolin; J Howard; Andrea G S Buggins; C Sneddon; G Castoldi; WJ Hirst; Ghulam J Mufti
Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes.
British journal of haematology 1999;107(4):844-50.
1999: Andrea G S Buggins; Nicholas C Lea; Joop Gäken; David Darling; Farzin Farzaneh; Ghulam J Mufti; WJ Hirst
Effect of costimulation and the microenvironment on antigen presentation by leukemic cells.
Blood 1999;94(10):3479-90.
1999: Aleksandar Mijovic; ANTONIO PAGLIUCA; Ghulam J Mufti
The "G-CSF test": the response to a single dose of granulocyte colony-stimulating factor predicts mobilization of hemopoietic progenitors in patients with hematologic malignancies.
Experimental hematology 1999;27(7):1204-9.
1999: Michael Brown; D H Davies; M A Skinner; G Bowen; SJ Hollingsworth; Ghulam J Mufti; John R Arrand; Simon N Stacey
Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors.
Cancer gene therapy 1999;6(3):238-45.
1998: Jane E Parker; Keith Fishlock; Aleksandar Mijovic; Barbara Czepulkowski; ANTONIO PAGLIUCA; Ghulam J Mufti
'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins.
British journal of haematology 1998;103(4):1075-82.
1998: R Pawson; DS Richardson; A Pagliuca; Stephen M Kelsey; S Hoque; J Breuer; Adrian C Newland; Ghulam J Mufti
Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases.
Leukemia & lymphoma 1998;31(1-2):177-85.
1998: ID Trayner; T Bustorff; A E Etches; Ghulam J Mufti; YJ Foss; Farzin Farzaneh
Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate.
Leukemia research 1998;22(6):537-47.
1998: A Mijović; Ghulam J Mufti
The myelodysplastic syndromes: towards a functional classification.
Blood reviews 1998;12(2):73-83.
1998: Aleksandar Mijovic; Keith Fishlock; ANTONIO PAGLIUCA; Ghulam J Mufti
Blast counts in blood progenitor cell (BPC) correlate with CD34+ cells and CFU-GM and are useful predictor of haemopoietic recovery after autologous BPC transplantation collections.
Bone marrow transplantation 1998;21(9):869-72.
1998: Aloysius Y Ho; ANTONIO PAGLIUCA; M N Maisey; Ghulam J Mufti
Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections.
British journal of haematology 1998;101(2):392-3.
1998: Jane E Parker; Ghulam J Mufti
Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes.
British journal of haematology 1998;101(2):220-30.
1998: Andrea G S Buggins; WJ Hirst; ANTONIO PAGLIUCA; Ghulam J Mufti
Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies.
British journal of haematology 1998;100(4):784-92.
1998: R Pawson; Ghulam J Mufti; A Pagliuca
Management of adult T-cell leukaemia/lymphoma.
British journal of haematology 1998;100(3):453-8.
1997: M McCarthy; John Ramage; AN McNair; Edward Gane; Bernard Portmann; A Pagliuca; Mohamed Rela; Nigel Heaton; Ghulam J Mufti; Roger Williams
The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients.
Journal of hepatology 1997;27(6):1015-21.
1997: Jane E Parker; ANTONIO PAGLIUCA; Aleksandar Mijovic; J O Cullis; Barbara Czepulkowski; S M Rassam; I R Samaratunga; R Grace; P A Gover; Ghulam J Mufti
Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia.
British journal of haematology 1997;99(4):939-44.
1997: Aloysius Y Ho; Aleksandar Mijovic; ANTONIO PAGLIUCA; Ghulam J Mufti
Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT).
Bone marrow transplantation 1997;20(11):1007-8.
1997: WJ Hirst; Andrea G S Buggins; David Darling; Joop Gäken; Farzin Farzaneh; Ghulam J Mufti
Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1.
Gene therapy 1997;4(7):691-9.
1997: J A Gaken; SJ Hollingsworth; WJ Hirst; Andrea G S Buggins; Joanna Galea-Lauri; M Peakman; Marcel Kuiper; P Patel; P Towner; P M Patel; Mary K Collins; Ghulam J Mufti; Farzin Farzaneh; David Darling
Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
Human gene therapy 1997;8(4):477-88.
1996: L Z He; J Stephenson; G Y He; Ghulam J Mufti
RAS gene mutations in Chinese leukaemia patients and members of a family with high incidence of leukaemia.
Leukemia research 1996;20(11-12):901-3.
1996: SJ Hollingsworth; David Darling; Joop Gäken; WJ Hirst; P Patel; Marcel Kuiper; P Towner; S Humphreys; Farzin Farzaneh; Ghulam J Mufti
The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.
British journal of cancer 1996;74(1):6-15.
1996: J Stephenson; Barbara Czepulkowski; WJ Hirst; Ghulam J Mufti
Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Leukemia research 1996;20(3):235-41.
1996: Jayesh Mehta; A Mijović; Ray Powles; ANTONIO PAGLIUCA; shashank singhal; Barbara Czepulkowski; G John Swansbury; Jennifer Treleaven; Ghulam J Mufti
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.
Bone marrow transplantation 1996;17(1):25-9.
1995: J Stephenson; H Lizhen; Ghulam J Mufti
Possible co-existence of RAS activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes.
Leukemia research 1995;19(10):741-8.
1995: J M Singer; Aleksandar Mijovic; K W Pettingale; A Nethersell; H J Dobbs; I R Samaratunga; A Lakhani; Ghulam J Mufti
VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1995;7(6):366-70.
1994: WJ Hirst; Ghulam J Mufti
The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes.
Leukemia research 1994;18(11):797-804.
1994: F D Davison; R S Kaczmarski; A Pozniak; Ghulam J Mufti; S Sutherland
Quantification of HIV by PCR in monocytes and lymphocytes in patients receiving antiviral treatment and low dose recombinant human granulocyte macrophage colony stimulating factor.
Journal of clinical pathology 1994;47(9):855-7.
1994: R S Kaczmarski; A D Webster; J Moxham; F Davison; S Sutherland; Ghulam J Mufti
CD4+ lymphocytopenia due to common variable immunodeficiency mimicking AIDS.
Journal of clinical pathology 1994;47(4):364-6.
1993: R S Kaczmarski; A Pozniak; A Lakhani; E Harvey; Ghulam J Mufti
A pilot study of low-dose recombinant human granulocyte-macrophage colony-stimulating factor in chronic neutropenia.
British journal of haematology 1993;84(2):338-40.
1993: WJ Hirst; Ghulam J Mufti
Management of myelodysplastic syndromes.
British journal of haematology 1993;84(2):191-6.
1993: WJ Hirst; Barbara Czepulkowski; Ghulam J Mufti
Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites.
Cancer genetics and cytogenetics 1993;65(1):51-7.
1993: R S Kaczmarski; Ghulam J Mufti
The pathophysiology and management of HIV-associated haematological abnormalities.
Haematologia 1993;25(1):1-17.
1992: R S Kaczmarski; F Davison; E Blair; S Sutherland; J Moxham; T McManus; Ghulam J Mufti
Detection of HIV in haemopoietic progenitors.
British journal of haematology 1992;82(4):764-9.
1992: R S Kaczmarski; Ghulam J Mufti; S Sutherland; G Yousef; F Davison; J Moxham; E Gane; R Williams
Idiopathic CD4+ T-lymphocytopenia.
Lancet 1992;340(8819):608; author reply 609.
1992: Ghulam J Mufti
Chromosomal deletions in the myelodysplastic syndrome.
Leukemia research 1992;16(1):35-41.
1992: M H Mangi; Ghulam J Mufti
Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
Blood 1992;79(1):198-205.
1991: R S Kaczmarski; Ghulam J Mufti
The cytokine receptor superfamily.
Blood reviews 1991;5(3):193-203.
1991: M H Mangi; D Mark Layton; K Tobal; Ghulam J Mufti
Cross-lineage rearrangement of antigen receptor genes in atypical chronic myeloid leukemia.
Leukemia 1991;5(3):210-3.
1991: M H Mangi; J R Salisbury; Ghulam J Mufti
Abnormal localization of immature precursors (ALIP) in the bone marrow of myelodysplastic syndromes: current state of knowledge and future directions.
Leukemia research 1991;15(7):627-39.
1990: R S Kaczmarski; Ghulam J Mufti
Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factor.
BMJ (Clinical research ed.) 1990;301(6764):1312-3.
1990: F Brito-Babapulle; H Pullon; D Mark Layton; A Etches; A Huxtable; M Mangi; A J Bellingham; Ghulam J Mufti
Clinicopathological features of acute undifferentiated leukaemia with a stem cell phenotype.
British journal of haematology 1990;76(2):210-4.
1990: ANTONIO PAGLIUCA; Ghulam J Mufti; M Janossa-Tahernia; S Eridani; N B Westwood; J Thumpston; B Sawyer; R Sturgess; R Williams
In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis--possible evidence of an occult myeloproliferative state.
The Quarterly journal of medicine 1990;76(281):981-9.
1990: K Tobal; ANTONIO PAGLIUCA; B Bhatt; N Bailey; D Mark Layton; Ghulam J Mufti
Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.
Leukemia 1990;4(7):486-9.
1990: A Pagliuca; Ghulam J Mufti; D Baldwin; A N Lestas; R M Wallis; A J Bellingham
Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.
Journal of clinical pathology 1990;43(4):277-81.
1990: ANTONIO PAGLIUCA; Ghulam J Mufti
Lead poisoning: an age old problem.
BMJ (Clinical research ed.) 1990;300(6728):830.
1990: ANTONIO PAGLIUCA; H Williams; J Salisbury; Ghulam J Mufti
Prodromal cutaneous lesions in adult T-cell leukaemia/lymphoma.
Lancet 1990;335(8691):733-4.
1990: H Hambley; Ghulam J Mufti
Erythropoietin: an old friend revisited.
BMJ (Clinical research ed.) 1990;300(6725):621-2.
1990: ANTONIO PAGLIUCA; R Kaczmarski; Ghulam J Mufti
Palmar-plantar erythema associated with combination chemotherapy.
Postgraduate medical journal 1990;66(773):242-3.
1989: K Tobal; D Mark Layton; Ghulam J Mufti
Non-invasive isolation of constitutional DNA for genetic analysis.
Lancet 1989;2(8674):1281-2.
1989: ANTONIO PAGLIUCA; H Hambley; Ghulam J Mufti
Coulter S Plus STKR histograms detect spurious elevation of leucocyte and platelet counts associated with cryoglobulinaemia.
Blut 1989;59(4):396-7.
1989: ANTONIO PAGLIUCA; D S Gillett; J R Salisbury; R N Basu; Ghulam J Mufti
Bilateral adrenal lymphoma presenting as Addison's disease.
Postgraduate medical journal 1989;65(767):684-6.
1989: ANTONIO PAGLIUCA; D Mark Layton; A Manoharan; S Gordon; P J Green; Ghulam J Mufti
Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases.
British journal of haematology 1989;71(4):499-504.
1988: ANTONIO PAGLIUCA; D Mark Layton; S Allen; Ghulam J Mufti
Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant.
BMJ (Clinical research ed.) 1988;297(6661):1456-7.
1987: ANTONIO PAGLIUCA; D Mark Layton; Ghulam J Mufti
Treatment for myelodysplastic syndromes.
Lancet 1987;2(8567):1095.